Glaukos to Present Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual MeetingBusiness Wire • 04/06/26
Glaukos Announces Commercial Availability of Epioxa™, a Transformative Innovation in Interventional Keratoconus CareBusiness Wire • 03/19/26
Glaukos Misses Q4 Earnings Estimates, Raises 2026 Revenue OutlookZacks Investment Research • 02/18/26
Glaukos (GKOS) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 02/10/26
Glaukos Announces US FDA Approval of NDA Supplement Allowing for Re-Administration of iDose® TRBusiness Wire • 01/28/26
Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17Business Wire • 01/20/26
Glaukos Corporation (GKOS) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/14/26
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue GuidanceBusiness Wire • 01/13/26
Glaukos Corporation (GKOS) Presents at Citi Annual Global Healthcare Conference 2025 TranscriptSeeking Alpha • 12/03/25
Glaukos (GKOS) Up 20% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 11/28/25
Glaukos Corporation (GKOS) Presents at UBS Global Healthcare Conference 2025 TranscriptSeeking Alpha • 11/11/25